% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{VishramNielsen:154464,
author = {J. K. K. Vishram-Nielsen and S. Laurent and P. M. Nilsson
and A. Linneberg and T. S. G. Sehested and S. V. Greve and
M. Pareek and L. Palmieri and S. Giampaoli and C.
Donfrancesco and F. Kee and G. Mancia and G. Cesana and G.
Veronesi and K. Kuulasmaa and V. Salomaa and J. Kontto and
T. Palosaari and S. Sans and J. Ferrieres and J.
Dallongeville and S. Söderberg and M. Moitry and W. Drygas
and A. Tamosiunas$^*$ and A. Peters$^*$ and H. Brenner$^*$
and I. Njolstad and M. H. Olsen},
collaboration = {M. Project},
title = {{D}oes {E}stimated {P}ulse {W}ave {V}elocity {A}dd
{P}rognostic {I}nformation?: {MORGAM} {P}rospective {C}ohort
{P}roject.},
journal = {Hypertension},
volume = {75},
number = {6},
issn = {1524-4563},
address = {Baltimore, Md.},
publisher = {Williams $\&$ Wilkins},
reportid = {DKFZ-2020-00786},
pages = {1420-1428},
year = {2020},
note = {2020 Jun;75(6):1420-1428},
abstract = {The Reference Values for Arterial Stiffness Collaboration
has derived an equation using age and mean blood pressure to
estimated pulse wave velocity (ePWV), which predicted
cardiovascular events independently of Systematic COoronary
Risk Evaluation (SCORE) and Framingham Risk Score. The study
aim was to investigate the independent association between
ePWV and clinical outcomes in 107 599 apparently healthy
subjects $(53\%$ men) aged 19 to 97 years from the MORGAM
Project who were included between 1982 and 2002 in 38
cohorts from 11 countries. Using multiple Cox-regression
analyses, the predictive value of ePWV was calculated
adjusting for country of inclusion and either SCORE,
Framingham Risk Score, or traditional cardiovascular risk
factors (age, sex, smoking, systolic blood pressure, body
mass index [BMI], total and high-density lipoprotein
cholesterol). Cardiovascular mortality consisted of fatal
stroke, fatal myocardial infarction, or coronary death, and
the composite cardiovascular end point consisted of stroke,
myocardial infarction, or coronary death. Model
discrimination was assessed using Harrell's C-statistic.
Adjusting for country and logSCORE or Framingham Risk Score,
ePWV was associated with all-cause mortality (hazard ratio,
1.23 $[95\%$ CI 1.20-1.25] per m/s or 1.32 [1.29-1.34]),
cardiovascular mortality (1.26 [1.21-1.32] or 1.35
[1.31-1.40]), and composite cardiovascular end point (1.19
[1.16-1.22] or 1.23 [1.20-1.25]; all P<0.001). However,
after adjusting for traditional cardiovascular risk factors,
ePWV was only associated with all-cause mortality (1.15
[1.08-1.22], P<0.001) and not with cardiovascular mortality
(0.97 [0.91-1.03]) nor composite cardiovascular end point
(1.10 [0.97-1.26]). The areas under the last 3 receiver
operator characteristic curves remained unchanged when
adding ePWV. Elevated ePWV was associated with subsequent
mortality and cardiovascular morbidity independently of
systematic coronary risk evaluation and Framingham Risk
Score but not independently of traditional cardiovascular
risk factors.},
cin = {C070 / C120},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32275189},
doi = {10.1161/HYPERTENSIONAHA.119.14088},
url = {https://inrepo02.dkfz.de/record/154464},
}